Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: KOSDAQ
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Daehwa Pharmaceutical Co Ltd

+ Add to Watchlist

067080:KS

8,330 KRW 130 1.59%

As of 00:17:25 ET on 03/04/2015.

Snapshot for Daehwa Pharmaceutical Co Ltd (067080)

Open: 8,190 Day's Range: 8,120 - 8,400 Volume: 125,865
Previous Close: 8,200 52wk Range: 6,350 - 10,250 1-Yr Rtn: +18.81%

Stock Chart for 067080

No chart data available.
  • 067080:KS 8,330
  • 1D
  • 1M
  • 1Y
8,200
Interactive 067080 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 067080

Current P/E Ratio (ttm) 87.8947
Estimated P/E(-) -
Relative P/E vs. KOSPI 2.9661
Earnings Per Share (ttm) 95.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 152,178.53
Shares Outstanding (M) 18.22
30 Day Average Volume 212,897
Price/Book (mrq) 2.4310
Price/Sale (ttm) 1.1428
Dividend Indicated Gross Yield 1.20%
Cash Dividend (KRW) 50.0000
Dividend Ex-Date 12/29/2014
5 Year Dividend Growth 0.00%
Next Earnings Announcement 05/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 067080

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 067080

Daehwa Pharm Co., Ltd. develops and manufactures a variety of pharmaceutical drugs, such as analgesics and anti-inflammatory drugs, antihistamines, skeletal muscle relaxants, and cardiovascular drugs.

Lee Han-KooChairman/CEO/Co-Rep DirectorKim Soo-JiCo-Rep Director
Kim Woon-JangHonorary ChairmanHan Gwon-SeokVice President
More Company Profile & Key Executives for 067080

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil